| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |